Clinical Trials Logo

Clinical Trial Summary

The main objective of the study is to show that the addition of ultrasonography to the dual tracer scintigraphy MIBI-Tc99m/Iodine-123 will increase (at least +5%) the negative predictive value compared to the dual tracer scintigraphy alone in detection of malignancy in thyroid nodules ≥15 mm classified as Bethesda III-IV on cytology.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT03498183
Study type Interventional
Source Nantes University Hospital
Contact Eric Mirallié, MD
Email eric/
Status Recruiting
Phase Phase 2/Phase 3
Start date January 17, 2019
Completion date July 1, 2021